We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Journées Internationales de Biologie 2006

By Labmedica staff writers
Posted on 22 Dec 2006
The annual Journées Internationales de Biologie (JIB) was held November 7-10, 2006, in Paris (France) under the auspices of the French Ministère de la Santé et des Solidarités and the Caisse Nationale d'Assurance Maladie (CNAM). More...


This annual clinical biology meeting in Europe combined an expanding trade show with 165 confirmed exhibitors and a high-level scientific program that focused on state-of-the-art and current practices in the medical laboratory. Aimed at biologists in both the private and hospital sectors, biomedical engineers, technicians, and hospital physicians, JIB provided extensive and comprehensive information on progress and technical advances in clinical biology.

Tunisia was the invited guest country at the JIB 2006, succeeding Belgium, Spain, Portugal, and Italy. The opening ceremony of the exhibition was held at the Tunisian pavilion, the "Médina Ibn Khaldoun” in the presence of Dr. Mohamed Ridha Kechrid, minister of health of Tunisia, Tijani Haddad, minister of tourism of Tunisia, and Mohamed Raouf Najar, ambassador of Tunisia in Paris. During the opening address, Dr. Mohamed Ridha Kechrid underlined the strong links that have been established between France and Tunisia's biologists, giving as an example the successful collaboration of the "Bio Quality Tunisia.”

The "Scientific Day of Tunisia” retraced the history of medicine and biology in Tunisia and highlighted the medical specificities of the country. It also focused on the quality system at the National Blood Transfusion Center in Tunisia, and gave insight into gastric pathologies and Helicobacter pylori infections, as well as hemoglobinopathies in Tunisia.

This year, the scientific panel, traditionally composed of the Journées Biologiques de Lariboisière, the Société Française de Biologie Clinique (SFBC), and L'institut Nationale de la Santé et de la Recherche Médicale (INSERM), also consisted of the Journées de Internat des Hôpitaux de Paris (JIPPIF), the Société Française Vitamines et Biofacteurs (SFVB), and the Société Francophone d'Etude et de Recherche sur les Eléments Toxiques et Essentiels (SFERETE).

The scientific program, which consisted of 12 sessions, about 100 speakers, and 130 poster sessions, was attended by over 1,600 delegates. It offered a unique opportunity to become acquainted with state-of-the-art information about rare diseases. New subjects that are likely to influence future practices in biologic investigations, such as molecular imaging and apoptosis as well as more classical aspects of biology, were discussed.



Related Links:
Journées Internationales de Biologie

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.